Clinical Trial Update: A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating edoxaban for resolving left atrial thrombosis in non-valvular atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Raffaele De Caterina | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED